Cryoablation vs. Lumpectomy
for Breast Cancer

Understanding two breast-conserving approaches

A breast cancer diagnosis carries important healthcare decisions with a lifelong impact.  Many women turn to lumpectomy, which removes a breast tumor through surgery. For eligible low-risk patients, cryoablation with ProSense® offers a minimally invasive option that destroys breast cancer by freezing it. If you are considering breast cancer cryoablation vs. lumpectomy, understand how the two approaches compare.

Cryoablation and Lumpectomy: Comparing Your Options

Understanding two breast-conserving approaches

A breast cancer diagnosis brings important treatment decisions. Lumpectomy removes the tumor through surgery. For eligible patients, cryoablation with ProSense® offers a minimally invasive option that destroys low-risk breast cancer by freezing it.

Understand how the two approaches compare.

Knowing your Options: Breast Cancer Cryoablation vs. Lumpectomy

For decades, lumpectomy has been a cornerstone of breast-conserving treatment for early-stage breast cancer. By surgically removing the tumor while preserving as much healthy breast tissue as possible, it has helped many patients avoid mastectomy while maintaining strong cancer-control outcomes. (Wang J, 2023). Today, treatment continues to evolve toward less invasive options for carefully selected patients. One of the most discussed approaches is cryoablation – a procedure that destroys tumor tissue by freezing it rather than removing it surgically.

If you’re comparing breast cancer cryoablation vs lumpectomy, we’re here to walk you through what each procedure involves, how they compare side-by-side, and what questions can help you and your care team decide what’s right for you.

What Is a Lumpectomy?

Lumpectomy, also called breast-conserving surgery, removes the cancerous tumor along with a margin of surrounding tissue. So, what is lumpectomy of the breast from a procedural standpoint? It’s typically performed in an operating room and may require general anesthesia or sedation. Depending on the diagnosis, lumpectomy is often followed by radiation therapy and may be combined with systemic treatments such as endocrine therapy, chemotherapy, targeted therapy, or immunotherapy.

The major advantage of lumpectomy is that it’s a long-established standard of care with extensive clinical evidence (Keelan S, 2021), well-defined pathology review, and broad guideline acceptance. Because the tumor is physically removed, physicians can examine the excised tissue to confirm clear margins and better understand the biology of the cancer.

The tradeoff between breast cancer cryoablation vs. lumpectomy is that surgery may involve incisions, scarring, temporary activity restrictions, discomfort, anesthesia-related risks, and a longer recovery period than minimally invasive procedures . In some cases, pathology may show that the surgical margins are positive or too close, meaning cancer cells are found at or near the edge of the removed tissue; when that happens, a second operation, called re-excision, may be recommended to remove additional tissue. According to studies, 14-20% (1) of patients may undergo re-excision after lumpectomy due to unclear margins. (Tamirisa, 2021).

(1) Mayo clinic article – Lumpectomy.

How Long Does a Lumpectomy Take?

As a surgical procedure, lumpectomy itself is usually completed within one to two hours, but the patient journey often starts much earlier than the operation. Many patients are asked to fast before surgery because anesthesia or sedation may be used, and those with non-palpable tumors may first meet with radiology for imaging-guided localization. During this step, the care team may use mammography, ultrasound, or another imaging method to confirm the tumor or biopsy marker location and place a wire, seed, clip, or other marker to help guide the surgeon. This preoperative localization can be clinically important, but it also adds time, coordination, and another procedure before the patient ever reaches the operating room. 

For many patients, that means more waiting while fasting, more transitions between departments, and more uncertainty on an already stressful day. As a result, total time at the surgical facility, including imaging, localization, preparation, anesthesia, the operation itself, and recovery monitoring, can span several hours even when the lumpectomy procedure is relatively short. Actual duration can vary depending on tumor size and location, whether a lymph node procedure is performed at the same time, and the specific localization and surgical techniques used.

Recovery and Reconstruction After Lumpectomy

Initial recovery from a lumpectomy generally takes one to two weeks (2), with full recovery and return to normal activity sometimes taking longer depending on whether radiation or other treatments follow. (Kunkler IH, 2023) Patients commonly experience swelling, bruising, and temporary changes in breast sensation.

A common question is whether breast tissue grows back after lumpectomy, and the answer is no. The tissue removed during surgery does not regenerate. Instead, the remaining breast tissue may shift or be reshaped, either naturally as swelling resolves or through oncoplastic and reconstructive techniques performed by the surgical team. Some patients are candidates for reconstruction or symmetry procedures at the time of surgery or afterward, which can help restore breast shape and appearance. This is an important considering when evaluating breast cancer cryoablation vs. lumpectomy. 

(2) Breastcancer.org – Recovery from Lumpectomy: What to Expect

What Is Cryoablation?

Cryoablation uses extreme cold temperatures to destroy tumor cells without surgical removal. A physician inserts a thin cryoprobe into the tumor under imaging guidance, typically ultrasound, creating an “ice ball” that encompasses the tumor and a margin of surrounding tissue. The frozen tissue is then gradually absorbed by the body over time.

IceCure’s ProSense® system uses liquid nitrogen (LN2) to freeze tumors and has been studied in low-risk, early-stage breast cancer as a short outpatient procedure, often performed under local anesthesia. To learn more about how the procedure works step by step, visit our Procedure page.

What Are the Benefits of Cryoablation?

For appropriately selected patients, cryoablation may offer several patient-centered benefits compared with surgical excision. Because no breast tissue is removed, the procedure may help maintain breast shape with minimal scarring, and breast reconstruction is typically not needed. In the ICE3 study, 99.1% of patients and 97% of physicians who responded to a survey reported being satisfied or very satisfied with breast cosmetic outcomes at five years.

Cryoablation is also a short, office-based or outpatient procedure, with an average procedure time of approximately 30 to 45 minutes and no overnight hospital stay. It is usually performed under local anesthesia, meaning numbing agents are injected only into the area being treated. The ice formed during treatment can also have a numbing effect, which may help reduce pain and discomfort.

Recovery is generally quick. Based on ICE3 study results, patients returned to normal activity within a median of one day, with a reported range of 0 to 8 days. For many patients considering breast cancer cryoablation vs. lumpectomy, this means a minimally invasive treatment experience with less disruption to daily life while preserving breast appearance and comfort.

Cryoablation and Lumpectomy Compared

Cryoablation Lumpectomy
How it treats the tumor Freezes and destroys the cells and a margin of surrounding tissue using a needle-like cryoprobe under imaging guidance. Surgically removes the tumor and a margin of surrounding tissue.
Setting Often performed as an outpatient or office-based procedure. Typically performed in an operating room or surgical center.
Anesthesia Usually local anesthesia; the cold itself adds a numbing effect. Often general anesthesia or sedation, depending on the case and institution.
Incision and scarring Very small skin entry point; usually minimal scarring. Requires a surgical incision; scar size and visibility vary.
Recovery time Minimal recovery time; the ICE3 study reported a median return to normal activity within one day. Recovery may take days to weeks; some patients have temporary movement restrictions.
Cosmetic outcome No breast tissue is removed, which may help preserve breast shape; high satisfaction reported in selected studies. Often good, but can be affected by tumor size, breast size, tissue removal, and radiation.
Pathology confirmation Tumor is not removed, so follow-up imaging and surveillance are especially important. Removed tissue can be examined to assess margins and tumor features.
Evidence base Growing evidence in carefully selected low-risk patients; long-term comparative data are still developing. Long-established standard of care with extensive long-term data.
Best suited for Selected patients aged 70 and above with small, low-risk, early-stage breast cancer, commonly hormone receptor-positive and node-negative, depending on local approval and physician judgment. Broadly used across many early-stage breast cancer scenarios when breast-conserving surgery is appropriate.
Potential limitations Not appropriate for all tumor types; requires careful selection, imaging follow-up, and adherence to recommended endocrine therapy when indicated. More invasive; may involve anesthesia, surgical recovery, scarring, and possible changes to breast appearance.

Which Option Is Right for You?

Cryoablation and lumpectomy reflect two different approaches to breast cancer treatment, and neither is automatically the “better” choice – it’s your choice, made together with your care team, based on your specific diagnosis and priorities.
Lumpectomy remains the benchmark for many patients, supported by decades of evidence and direct pathological assessment after removal (3). It may be the more appropriate path for larger tumors, higher-risk biology, multifocal disease, lobular histology, lymph node involvement, or other features that make local control more complex.

Criteria for Breast Cancer Cryoablation

For patients who do meet the criteria, though, cryoablation offers a compelling combination: comparable local control in the studies conducted so far, without the surgical excision, general anesthesia, or extended downtime that come with a lumpectomy. The American Society of Breast Surgeons’ updated 2026 Resource Guide on transcutaneous and percutaneous breast tumor ablation recommends cryoablation as an option for selected patients with biologically low-risk, early-stage breast cancer, reinforcing its growing role in appropriately selected cases (3).

Clinical Evidence 

IceCure’s ICE3 trial reported a 3.1% local recurrence rate among patients treated with cryoablation and endocrine therapy, a median return to normal activity within one day, and high satisfaction with cosmetic outcomes – patients kept their breast shape without ever going under the knife. The THERMAC trial similarly found ProSense® cryoablation achieved the highest complete ablation rate among thermal ablation methods studied, with favorable cosmetic results. (Wooldrik S, 2025).

As with any newer technique, larger and longer-term comparative studies are still underway, and cryoablation isn’t the right fit for every diagnosis. But for the growing number of patients who do qualify, it’s increasingly seen as a way to achieve strong cancer control with meaningfully less disruption to daily life and with minimal scarring, making it well worth raising with your care team as an option alongside lumpectomy.

(3) ASBrS Resource guide on breast conserving surgery

FAQs: Cryoablation vs. Lumpectomy

The procedure itself typically takes one to two hours, though patients should plan for additional time at the surgical facility for preparation and recovery monitoring. Most lumpectomies are same-day, outpatient procedures.

Breast cancer cryoablation is typically a short outpatient procedure which often takes about 30 to 45 minutes. Unlike lumpectomy, cryoablation is commonly performed under local anesthesia with ultrasound guidance, and many patients are able to return to normal activity within 24 hours, with the ICE3 trial reporting a median return to normal activity within one day.

No. Breast tissue removed during a lumpectomy does not regenerate. Surrounding tissue may shift naturally or be reshaped through oncoplastic or reconstructive techniques to help restore breast appearance.

After cryoablation, the frozen tumor tissue is not surgically removed from the breast. Instead, the freezing and thawing process causes cancer cells in the targeted area to die. Over time, the body’s natural healing and immune processes gradually break down and clear the treated tissue, and the ablation zone typically becomes smaller or changes in appearance on follow-up imaging. Because the tumor remains in place initially, ongoing imaging surveillance is important so the care team can monitor the treated area and evaluate potential changes or possible recurrence.

Helpful questions include:

  • What are the expected margins, and what happens if they aren’t clear?
  • Will radiation or other systemic treatments be needed afterward?
  • What will recovery look like, and are there activity restrictions?
  • What are the cosmetic and reconstruction options?
  • Does my diagnosis make me a candidate for a less invasive option like cryoablation, and if so, what would that mean for my recovery and results?
  • Am I a good candidate for cryoablation?
  • How is the procedure done? Will I need anesthesia or sedation?
  • What are the benefits compared with lumpectomy? What are the possible risks or side effects of cryoablation?
  • How will you know the tumor was fully treated? What follow-up imaging will I need?
  • Will I still need radiation or other adjuvant therapies afterward?
  • How much experience do you have with breast cryoablation?
Disclaimer:

This article is for educational purposes only and does not replace medical advice. Patients should discuss treatment options with a qualified breast cancer care team.

References:
  1. Chakedis JM, C. S. (2022). ssessment of Surgeon Factors Associated With Margin Re-excision After Breast-Conserving Surgery. JAMA Netw Open.
  2. Fine RE, G. R. (2024). Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Ann Surg Oncol., 7273-7283.
  3. Keelan S, F. M. (2021). Evolving Trends in Surgical Management of Breast Cancer: An Analysis of 30 Years of Practice Changing Papers. Front Oncol.
  4. Kunkler IH, W. L. (2023). Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N Engl J Med., 585-594.
  5. Tamirisa, N. L. (2021). Impact of SSO-ASTRO “No Ink on Tumor” Guidelines on Reexcision Rates among Older Breast Cancer Patients. Ann Surg Oncol, 3703-3713.
  6. Wang J, Z. S. (2023). Comparative Effectiveness Analysis of Lumpectomy and Mastectomy for Elderly Female Breast Cancer Patients: A Deep Learning-based Big Data Analysis. Yale J Biol Med. , 327-346.
  7. Wooldrik S, v. d. (2025). Cosmetic outcome and patient satisfaction following percutaneous thermal ablation of early-stage breast cancer; results of an open label randomized phase 2 trial. Eur J Surg Oncol. 

Resources

Publications

Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients

A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.

Read More >

Publications

Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer

Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.

Read More >

Publications

Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study

Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.

Read More >